genedrive (LON:GDR) Trading Down 8% – Here’s Why

Shares of genedrive plc (LON:GDR) were down 8% during mid-day trading on Tuesday . The stock traded as low as GBX 2.25 ($0.03) and last traded at GBX 2.30 ($0.03). Approximately 1,411,990 shares changed hands during trading, a decline of 89% from the average daily volume of 13,075,102 shares. The stock had previously closed at GBX 2.50 ($0.03).

genedrive Stock Performance

The company has a market capitalization of £12.49 million, a PE ratio of -57.48 and a beta of -0.04. The company has a debt-to-equity ratio of 8.57, a current ratio of 1.63 and a quick ratio of 5.52. The stock has a 50-day simple moving average of GBX 2.30 and a 200 day simple moving average of GBX 2.43.

Insider Buying and Selling

In other news, insider Ian David Gilham bought 225,000 shares of the stock in a transaction on Friday, December 20th. The stock was purchased at an average cost of GBX 2 ($0.03) per share, with a total value of £4,500 ($5,641.22). Insiders own 14.75% of the company’s stock.

genedrive Company Profile

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.